Five publications from the past week:
- Clinical exome sequencing vs. usual care for hereditary colorectal cancer diagnosis: A pilot comparative effectiveness study | link
- Health outcomes, utility and costs of returning incidental results from genomic sequencing in a Canadian cancer population: protocol for a mixed-methods randomised controlled trial | link
- Measuring clinical utility in the context of genetic testing: a scoping review | link
- Expanding Use of Clinical Genome Sequencing and the Need for More Data on Implementation | link
- Implementing Interventions with Varying Marginal Cost-Effectiveness: An Application in Precision Medicine | link
I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics!
4 thoughts on “New publications in health economics and genomics 27th October 2020”
Wright SJ, Paulden M, Payne K. Implementing Interventions with Varying Marginal Cost-Effectiveness: An Application in Precision Medicine. Medical Decision Making. 2020 Oct;40(7):924-38.
Phillips KA, Douglas MP, Marshall DA. Expanding Use of Clinical Genome Sequencing and the Need for More Data on Implementation. JAMA. October 2020. doi:10.1001/jama.2020.19933
Thanks Raymond. Two papers that I did know about but inexplicably left off my list. Apologies to the authors! I shouldn’t make these blog posts late at night…
That’s James, I use Google Scholar to pick up any Health Economics/Precision Medicine articles I don’t get from your twitter feed, but you have to kiss a lot of frogs! 😉